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A 24-year-old male presented with 4 cm × 5 cm-sized polypoidal orbital mass for 8 years, gradually progressive with proptosis of the right eyeball. There was no lymphadenopathy or hepatosplenomegaly. Computed tomography revealed a homogeneous enhancing soft tissue polypoidal mass in the lateral aspect of the right orbit and pushing the eyeball medially. Fine-needle aspiration cytology (FNAC) was performed from the polypoid orbital mass. The diagnosis was offered after cytomorphologic evaluation and flow cytometric immunophenotyping [ Figure 1 ].
See next pages for answer (and additional Quiz questions, Page 2). The correct cytological interpretation is -This is a case of primary mantle cell lymphoma of the orbit.
DISCUSSION
Lymphomas primarily involve the axial lymph node groups; although the NHL may also involve extranodal tissues such as nasopharynx, tonsils, gastrointestinal tract, brain, heart, and skin. Ten percent of systemic lymphomas have orbital involvement; however, in <1% cases, lymphoma develops primarily in the orbit. [1] Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT)-type is a common type of NHL affecting eye and orbit. Mantle cell lymphoma is a rare entity at this site, which is characterized by the presence of small to medium-sized lymphoid cells with irregular nuclear outlines, often cleaved with condensed chromatin, tiny to absent nucleoli, and scanty slightly basophilic cytoplasm. It is a rare subtype of B-cell NHL occurring in an orbital region with only a few reported cases and case series in literature. [2] [3] [4] [5] [6] [7] [8] Rasmussen et al. [8] identified 21 patients of mantle cell lymphoma in the orbital and adnexal region comprising 9% of all lymphomas in the ocular region. Elderly males were more commonly affected. The orbit (71%) and eyelids (64%) were the most commonly affected sites. Another report [7] has shown similar results that orbital mantle cell lymphoma has an aggressive clinical course and patients usually present with advanced disease. The present case is a young male with a long history of orbital mass, without any associated systemic findings or peripheral lymphadenopathy. Another case of orbital mantle cell lymphoma has been reported in a 31-year-old female from Nepal, who presenting with orbital swelling of 9-month duration. [9] The various modalities useful for differentiating lymphoproliferative disorders involving orbital region include histopathological examination, immunochemistry, flow cytometry, cytogenetics, and new technologies such as real-time polymerase chain reaction and fluorescence in situ hybridization. The final diagnosis can be given based on combined results of various ancillary techniques. In the present case, FNAC of the orbital mass revealed a population of atypical lymphoid cells having irregular indented nuclei, admixed with plasma cells, histiocytes, and reactive mature lymphocytes. FCI was performed on the aspirated material, which confirmed a clonal population of B lymphoid cells with CD5-positive and CD23-negative cells, the most compatible diagnosis being mantle cell lymphoma. The tumor cells of MALT lymphoma are positive for CD19, CD20, CD79a and negative for CD23; however, they are also negative for CD5, thus differentiating it from mantle cell lymphoma. A definitive diagnosis of mantle cell lymphoma should be offered after demonstration of t(11;14) (q13;q32) translocation or cyclin D1 overexpression, which could not be performed in the present case. 
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